BIOEXTRAX AB (85X0) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BIOEXTRAX AB (85X0) has a cash flow conversion efficiency ratio of 0.455x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€7.68 Million ≈ $8.97 Million USD) by net assets (€16.89 Million ≈ $19.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 85X0 market cap overview for the company's overall valuation and market capitalisation.
BIOEXTRAX AB - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how BIOEXTRAX AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View BIOEXTRAX AB (85X0) share price today for real-time trading data and today's change.
BIOEXTRAX AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BIOEXTRAX AB ranked by their cash flow conversion efficiency. Review 85X0 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
mVISE AG
XETRA:C1V
|
0.092x |
|
Centrex Ltd
AU:CXM
|
-0.301x |
|
Txcom SA
PA:ALTXC
|
-0.023x |
|
Spring Art Holdings Bhd
KLSE:0216
|
0.013x |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
0.213x |
|
Nusantara Voucher Distribution Tbk PT
JK:DIVA
|
0.016x |
|
Tian An Australia Ltd
AU:TIA
|
0.083x |
|
Hiap Huat Holdings Bhd
KLSE:0160
|
0.130x |
Annual Cash Flow Conversion Efficiency for BIOEXTRAX AB (2021–2025)
The table below shows the annual cash flow conversion efficiency of BIOEXTRAX AB from 2021 to 2025. Also see BIOEXTRAX AB total assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €21.21 Million ≈ $24.80 Million |
€-26.05 Million ≈ $-30.45 Million |
-1.228x | -70.38% |
| 2024-12-31 | €26.06 Million ≈ $30.47 Million |
€-18.78 Million ≈ $-21.95 Million |
-0.721x | +36.52% |
| 2023-12-31 | €20.54 Million ≈ $24.01 Million |
€-23.31 Million ≈ $-27.25 Million |
-1.135x | -104.83% |
| 2022-12-31 | €31.77 Million ≈ $37.14 Million |
€-17.60 Million ≈ $-20.58 Million |
-0.554x | +50.98% |
| 2021-12-31 | €7.50 Million ≈ $8.77 Million |
€-8.48 Million ≈ $-9.91 Million |
-1.130x | -- |
About BIOEXTRAX AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. The company produces PHA (polyhydroxyalkanoates), a group of bio-based and biodegradable bioplastics that replace fossil-based plastics; PHBV, a stiff, high-performance polymer; and PHO, a soft, flexible, and smooth biopolymer with rubbery properties. It also provides hydrolysates protein for animal feed; … Read more